107 results
8-K
EX-99.1
FGEN
FibroGen Inc
6 May 24
FibroGen Reports First Quarter 2024 Financial Results
4:05pm
facilities, non-current
Liability related to sale of future revenues, non-current
Other long-term liabilities
Total liabilities
Redeemable non-controlling
8-K
EX-99.1
t0jtp3ha73f6hblwtw7
26 Feb 24
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
8-K
EX-99.1
icdf hwrm2
6 Nov 23
FibroGen Reports Third Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
g5p3n9b knwh2ed4i3gf
7 Aug 23
FibroGen Reports Second Quarter 2023 Financial Results
4:06pm
DEFA14A
yzbc8d nn09e1
31 May 23
Additional proxy soliciting materials
9:00am
8-K
EX-99.1
49z1nm0p
18 May 23
FibroGen Announces Positive Topline Results from China Pivotal Phase 3 Clinical Trial of Roxadustat for the Treatment of Chemotherapy Induced Anemia
7:35am
8-K
EX-99.1
ux3 i8klvbfs
8 May 23
FibroGen Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
hj1r598q90nkit0
7 Nov 22
FibroGen Reports Third Quarter 2022 Financial Results
4:06pm
S-3ASR
EX-1.2
ivzoun347jn
8 Aug 22
Automatic shelf registration
5:12pm